Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251
- 1 March 2002
- journal article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 16 (2) , 139-143
- https://doi.org/10.1177/026988110201600204
Abstract
Cannabinoids are drugs that are frequently abused not only alone, but also in combination with other drugs. The present study investigated possible functional interactions between the psychostimulant methamphetamine and the cannabinoid receptor agonists anandamide, or R-(+)-methanandamide and cannabinoid antagonist AM 251 in the rat model of i.v. drug self-administration. In rats trained to self-administer methamphetamine, the intake was significantly decreased by the cannabinoid antagonist and tended to be dose-dependently increased by pre-treatment with cannabinoid receptor agonists. Possible mechanisms for these drug interactions are discussed and the use of the cannabinoid antagonist for the treatment of drug abuse is considered.Keywords
This publication has 31 references indexed in Scilit:
- Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological studyNeuroscience, 2000
- Methamphetamine Rapidly Decreases Vesicular Dopamine UptakeJournal of Neurochemistry, 2000
- Precipitated and spontaneous withdrawal in rats tolerant to anandamidePsychopharmacology, 2000
- Recovery of Presynaptic Dopaminergic Functioning in Rats Treated with Neurotoxic Doses of MethamphetamineJournal of Neuroscience, 1999
- The effects of cannabinoids on the brainPublished by Elsevier ,1999
- Mesolimbic dopaminergic decline after cannabinoid withdrawalProceedings of the National Academy of Sciences, 1998
- Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders1Presented in part at the National Marijuana Conference of the National Institute on Drug Abuse, Washington, D.C., on 20 July 1995.1Drug and Alcohol Dependence, 1998
- Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid WithdrawalScience, 1997
- (R)-methanandamide, but not anadamide, substitutes for Δ–9-THC in a drug-discrimination procedure.Experimental and Clinical Psychopharmacology, 1997
- Ventral tegmental microinjection of Δ9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredientBrain Research, 1993